Patent · US Expired

Imidazonaphthyridines

US6894165B2 · kind B2 · utility

31Cited by
49References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 14, 2004
Grant dateMay 17, 2005
Priority date
Expiry dateApr 14, 2024

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor. The compounds exhibit antiviral and antitumor properties. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.